Cross-Site Scripting Vulnerability in HPE Diagnostics by Hewlett Packard Enterprise
CVE-2016-8522

5.4MEDIUM

Key Information:

Vendor

HP
Status
Diagnostics
Vendor
CVE Published:
15 February 2018

What is CVE-2016-8522?

A cross-site scripting vulnerability in HPE Diagnostics versions 9.24 IP1, 9.26, and 9.26IP1 allows attackers to inject malicious scripts into web pages viewed by users. This could enable unauthorized access to sensitive information and facilitate further exploitation of the affected system. Organizations using these versions should apply relevant patches and adhere to security best practices to mitigate risks associated with this vulnerability.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Diagnostics 9.24 IP1, 9.26 , 9.26IP1

References

https://support.hpe.com/hpsc/doc/public/display?docId=emr...
x_refsource_CONFIRM
http://www.securitytracker.com/id/1037602
vdb-entryx_refsource_SECTRACK
http://www.securityfocus.com/bid/95427
vdb-entryx_refsource_BID

CVSS V3.1

Score:
5.4
Severity:
MEDIUM
Confidentiality:
Low
Integrity:
Low
Availability:
Low
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
Required
Scope:
Changed

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.